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Abstract
Background: The randomised control trial (RCT) is the most rigorous method of evaluating interventions. Recruitment
is often slower and more challenging than expected. The aim of the current paper is to understand the feasibility of
recruitment within the NHS and the barriers and motivators to recruitment from the perspective of patients and
healthcare professionals (HCPs).
Methods: NHS HCPs were surveyed to establish their willingness to participate. Twenty HCPs were interviewed to
establish barriers and motivators to recruitment. Eleven patients were interviewed to understand their willingness to
participate. Interviews were analysed using thematic analysis.
Results: HCP interviews identified key barriers to recruitment: practical barriers included workload and time; clinical
barriers included terminology and concern that the trial implied criticism of their current practice; and patient barriers
included gender and cultural factors. Motivators to recruitment included: regular communication between research
and clinical teams; feedback on findings; and patient and individual benefits for clinicians. Patient interviews suggested
that participation in a trial of a psychosocial intervention would strengthen existing coping skills and develop
mechanisms for those who were struggling.
Conclusions: Survey results demonstrated that recruitment to an RCT of a psychosocial intervention for people living with
and beyond cancer would be feasible within the NHS if specific barriers are addressed. From a clinician point of view, barriers
should be addressed to improve recruitment, particularly training and education of clinicians and clear communication.
From a patient perspective, interventions and RCT should be tailored to target those not routinely represented in RCTs.
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Background
In randomised control trials (RCTs), participants are
randomly assigned to two or more clinical interventions
to reduce bias. The RCT is seen as the most scientifically
rigorous method of evaluating the effectiveness of inter-
ventions and is widely regarded as the gold standard in
experimental research design [1]. RCTs are important to
establish the evidence base for clinical practice in the
NHS [2]. Recruitment targets are set to avoid study find-
ings being statistically underpowered, which may lead to a
Type I or Type II error with researchers erroneously de-
tecting an effect where none exists or failing to detect an
effect that is, in fact, present. Such errors can result in in-
terventions being provided that lack benefit or, conversely,
patients being denied interventions that could significantly
improve their health and quality of life (QoL) [3].
Recruitment to trials is frequently much slower and
more challenging than expected, with up to 66% of trials
not achieving their target sample size [4] and 53% of
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trials being required to extend the recruitment period,
which increases costs and delays the application of re-
search findings to clinical practice [5]. Reasons for un-
met targets and delays included issues with local clinical
arrangements, with some trials reporting pre-identified
centres not participating as planned [5]. Losses of eli-
gible participants were attributable to refusals by pa-
tients in 25% of trials and refusals by physicians to
recruit in 29% of trials [4]. Achieving set recruitment
targets is of paramount importance for the success of a
RCT. An understanding of the factors that influence re-
cruitment is therefore vital when planning a RCT.
When considering what may increase motivation to
recruit, a monetary incentive is considered less import-
ant than factors such as interest in the research, patient
benefit and good communication [6]. A systematic re-
view of effective mechanisms to increase the recruitment
activity of clinicians involved in RCTs suggested the use
of qualitative research to identify and overcome barriers
to recruitment, clinicians having a reduction in expected
clinical workload when working on RCTs, and training
being provided [7]. Good communication with the re-
search team, a clear beneficial effect on patients and
clinical practice, an understanding of the purpose of the
research, and the individual benefit for clinicians aided
recruitment, while HCPs’ perception that barriers are
patient-related and out of their control was a barrier [7].
The ProtecT (Prostate testing for cancer and Treatment)
RCT used qualitative methods to analyse recruitment
discussions and data from interviews with potential partici-
pants. Findings suggested that within recruitment to the
trial, recruiters had difficulty discussing equipoise and
presenting treatments equally, often inadvertently using ter-
minology difficult for patients to interpret [8]. The ProtecT
trial successfully optimised recruiters’ communication strat-
egies to increase recruitment rates and demonstrated the
benefits of qualitative methods being included either at the
feasibility stage of a RCT, or fully integrated into the RCT
[9]. The Quartet (Qualitative research to improve
recruitment to randomised controlled trials) study collabo-
rated with trial management groups to improve recruitment
in trials experiencing poor recruitment by focusing on the
way that trials were presented to potential participants [9].
Recruitment to trials with patients with mental health
problems face similar issues to trials in general, but there
are additional considerations which are specific to this
population [10]. The five main reasons for recruitment
difficulties in such trials include: misconceptions about tri-
als; a perception of lack of equipoise; HCPs misunder-
standing the trial arms and eligibility; and staff
paternalism regarding their role as a ‘carer’ [10]. These
findings have relevance for planning a RCT of a
psychosocial intervention for people living with and
beyond cancer.
The aim of this research was therefore to establish the
feasibility of recruiting participants to a RCT of a
psychosocial intervention designed to improve the QoL of
those living with and beyond cancer. In particular, it
examined:
1. the willingness of clinics across the NHS to
participate in such a RCT;
2. barriers and motivators to recruitment, with a
particular focus on cultural barriers;




The approval for the survey as a service evaluation was
gained via Bart’s Health NHS Trust (Reg. No. 6131). The
four-item scale used was drawn from a larger 22-item stan-
dardised survey [11]. The questionnaire items can be found
in Table 1. Questions were asked to all participants regard-
less of their response to item 1. The short survey was sent
to a range of professional bodies to try to capture all relevant
HCPs involved in the management of cancer patients work-
ing in a range of clinical settings. These included the Associ-
ation of Cancer Physicians, the UK Oncology Nurses
Society, the Royal College of Radiologists, the UK Breast In-
tergroup, British Psychological Society and the Association
of Coloproctology of Great Britain and Ireland. The profes-
sional bodies distributed the survey to their members via an
email link that was open from August to December 2015.
The participants completed the survey through the online
tool SurveyMonkey (www.surveymonkey.com). Descriptive
analysis was used to create proportions with the survey data.
Interviews with HCPs
The approval for the interviews with HCPs as a service
evaluation was gained via Barts Health NHS Trust (Reg.
No. 7070). HCPs who were potential recruiters working
within Bart’s Health NHS Trust and University College
Hospital were first approached by email to participate in a
10–15-min semi-structured in-person or telephone inter-
view. Consent was sought to record the interview. HCPs
were asked about the feasibility of recruiting patients who
had finished active treatment; their confidence in (i)
explaining a trial, (ii) identifying those with low QoL, (iii)
using screening measures; and barriers and motivators to
recruiting to a trial within clinics. Interviews were anon-
ymised and transcribed verbatim. Transcripts were analysed
using thematic analysis. MD immersed herself in the data,
highlighting key sections of text to develop an initial list of
codes using the qualitative data analysis software NVivo.
The list was then debated with GE to sort into key themes.
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A table of the full list of themes and codes can be found in
the Appendix.
Interviews with patients
Ethical approval was obtained for this part of the study
(Health Research Authority NRES Committee East of
England, REC reference: 15/EE/0198 IRAS project ID
168246). Patients who had completed active treatment for
cancer were approached in Bart’s Health NHS Trust out-
patient clinics and asked whether they would participate
in a single semi-structured interview to explore their po-
tential willingness to participate in a trial of a psychosocial
intervention aimed at improving QoL. Patients were re-
cruited consecutively but with the aim of including people
diagnosed with different types of cancer. To be eligible to
participate, patients must have finished active treatment
and be aged > 18 years. Patients were excluded if they
were not able to speak English. The interviews lasted
around 40–90 min and were recorded and transcribed.
Analysis proceeded as for the interviews with HCPs.
Results
Survey of HCPs
There were a total of 278 responses, of which 166 had com-
pleted all four questions resulting in a 60% completion rate.
One hundred and eight of the 154 (70%) acute NHS trusts
were represented in the survey. We received responses from
the Association of Cancer Physicians, the UK Oncology
Nurses Society, the Royal College of Radiologists and the
UK Breast Intergroup. No response was obtained from The
British Psychological Society and the Association of Colo-
proctology of Great Britain and Ireland. We were unable to
calculate an absolute response rate as the respective profes-
sional bodies acted as intermediaries in the process in order
to protect the privacy of their members and handled dissem-
ination of the survey link. The survey responses to questions
asking about participating in a trial can be found in Table 1.
Interviews with HCPs
In total, 20 HCPs participated in the interview: six Clin-
ical Nurse Specialists and 14 Consultants. HCPs were
working in a variety of areas of cancer: nine colorectal,
six breast, three head and neck, one haematology and
one prostate cancer clinician. Thematic analysis revealed
four key themes: practical barriers; clinical barriers; pa-
tient barriers; and motivators to improve recruitment.
Practical barriers
HCPs identified barriers to recruitment that were out of
their control, such as under-resourced staff, limited time
within clinic, workload concerns in a busy clinic and the
recruitment to other ongoing trials.
One of the things we are facing at the minute are just
how busy clinics are and there’s lots of the new
technology coming in like new electronic systems, which
means clinic time is squeezed even more. So, what I am
certainly finding is I am spending less time with patients
and more time at a computer screen, and I am sure
that would have a knock-on effect potentially with trials.
Clinical skills barriers
Clinical skills barriers included factors relating to the cli-
nicians perceived ability to promote a RCT. The termin-
ology used and equipoise of clinicians was raised as an
issue to recruitment:
I think the wording would probably need to be
changed – I think those words are all very
understandable to us as clinicians and scientists but if
I said to my average patient, how is your quality of
life, they would not necessary know what that means
so I think there would need to be some description.
Other clinical barriers that were highlighted included
the risk of clinicians viewing a RCT, especially in psych-
ology, as criticism of their current practices:
The main barrier was that because we think we have
quite a good set up already one of the nurses was a bit
sort of suspicious of the study that it was here to sort
of investigate what we do.
The final barrier from clinicians was remembering to
mention a RCT to patients within a busy clinic, espe-
cially with multiple RCTs to recruit from:
Table 1 Survey response to participating in a randomised control trial
Yes No Not sure
1. Would your unit be interested, in principle, in participating as a centre in a randomised controlled trial of
an intervention to improve quality of life of those living with and beyond cancer?
71% [118] 5% [8] 24% [40]
2. In principle, would you be willing to release one or two members of nursing or therapy staff, for three days
in total, for training in the intervention and delivery of therapy?
55% [91] 7% [11] 38% [64]
3. In principle, would you be willing to allow the staff who have been trained to then run the therapy in their unit? 68% [110] 3% [5] 29% [48]
Participants who responded yes to question 1 were asked how many days a HCP could be spared from their service for training; 73 participants responded, with a
mean of 1 day (SD = 1.15)
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The difficult bit is remembering and identifying the
people who and remember to ask.
Patient barriers
It was a general consensus among clinicians that there
would be a certain group of patients that would simply
not be interested in a RCT or psychological support:
There are some patients you will find will want to
access everything and there are some patients that will
just want to go away and forget it all.
However, some HCPs identified specific potential bar-
riers relating to the patients included demographic fac-
tors such as gender and cultural factors:
Now I do not want to be sexist but it’s just how I find it,
with head and neck cancer it’s very much still such a
male-dominated cancer but often they do not like these
sorts of things that touch on the psychological aspects,
because they are a man and they have got to be strong.
It’s not language, it’s culture because people have a lot of
people of non-European origin, non-western European
origin, intrinsically they do clinical studies, they enjoy it.
So, our recruitment is always lower than it should be,
just because of that cosmopolitan effect.
Furthermore, HCPs suggested that RCTs should focus on
educational requirements and mental health problems that
may prevent a patient from completing extensive outcome
measures:
Quite a lot of our patients have mental health
problems, which might mean they do not want to
engage in this sort of thing.
A significant amount of our patients are from a low
socio-economic background and do not always have
great educational skills. But in an interview, they
would be fine but I know sometimes they struggle with
the long questionnaires.
Motivators to improve recruitment
After identifying the barriers to recruitment, HCPs
highlighted factors that may improve recruitment. These
included regular contact with the research team and/or
research staff within clinics:
We certainly know the best recruiting studies are the
ones that have either the research assistant or whoever
actually in clinic reminding clinicians of the study,
making sure we are asking the questions and giving
the patients information.
The HCPs were more specific about the contact with
the research team and felt updates on patient benefits
would improve motivation:
Feedback from patients about how it helped them fed
to the recruiting clinicians so we can see how it’s being
helpful.
HCPs felt that communication was also key through-
out the whole clinical team surrounding the patients.
The clinicians should be aware of the RCT and actively
promote it within clinics:
Making sure all members of the team whether it be
me, a CNS, a ward nurse or a radiographer are saying
the same thing. Because it’s almost that attrition and
you say it enough times to a patient and they sort of
give in. So I think that’s an important thing to make
sure we are not saying different things and it’s not just
one of us continuously saying it but it’s the team.
Important factors to promote HCPs recruiting patients
included both personal benefit such as ‘being acknowl-
edged in papers’ and wider patient benefits:
Just the fact that trials help in the future, so it’s just
the fact that every trial is successful and will help
many more patients.
HCPs felt that more in depth preparation for recruit-
ment to a RCT trial may help, such as ‘more written
information, and probably short teaching sessions’.
Interviews with patients
Eleven patients completed the interview: four head and
neck cancer patients; four haematology patients; and three
breast cancer patients. Demographic information can be
found in Table 2.
Patients’ opinion was divided on whether they would
personally participate in the intervention, but they
believed it should be provided to those that need the
support. Thematic analysis resulted in four main themes
for those that would take up the intervention—positives
of the intervention, timing of the intervention—and for
those that would not—current coping mechanisms and
positives of the intervention for others.
The patients that said they would personally be inter-
ested in taking part felt that the intervention would im-
prove aspects such as fatigue, returning to work and
depression:
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If people are feeling really tired, I think for them that
would be good because it’s something positive because I
think it might be quite easy to look at the negatives
and hang on to them.
I wanted to get back to work, but I really did not want to
face anybody, because I am on reception so I did not want
the constant, ‘How are you feeling? Duh-duh-duh-duh-
duh.’ It’s like, yes, I needed to just get back to normal. Yes,
it’s the initial first going back, the first week was hard.
If they have a couple of follow-up things then it might
be you won’t… you will be depressed but you won’t be
depressed as intense[ly].
These patients further suggested that the timing of the
intervention being offered was important:
If it was offered to me when first discharged I may
have considered it at the time, but as that wasn’t
offered at the time then….
The feeling of elation is unbelievable, to be told
that you are free of cancer… I wish I had not have
had to have that experience but to have had it you
cannot describe that feeling and that may override
everything else that’s going on up here at that
moment in time. So it might be that this needs to
settle down a bit, so a month or so later say ‘Look,
just, if you feel that you want it, here’s our contact
number, get in touch.’ These people might cope with
it perfectly well anyway.
The patients that said that they would not be person-
ally interested tended to report current coping mecha-
nisms such as acceptance and exercise:
I probably would not but only because of the fact I
have someone that I talk to and I think I am working
on that generally, accepting that you cannot control
everything in life.
I think I am fine because I think I have accepted I
cannot chew salad with people, cannot do that.
I think I am quite lucky that I feel into gym and
that is my let up, but I think for other people, yeah,
if people are feeling really tired, I think for them
that would be good because it’s something positive
because I think it might be quite easy to look at the
negatives and hang on to them.
However, they felt that the intervention should be
available to those that may need it:
In my particular case I don’t think so, but in general I
think it would be a good idea. But those who don’t
have that therapist and counselling would be very
good, but those are… because I’m very outward, I do
go out and talk to people and make myself busy and
everything, but some people are not like that. So for
those kinds of people it would be nice for people go
and have a chat because instead of being a lonely
person they can go and chat with somebody and tell
their problems and somebody is there to listen to them
and you get advice on that. I think that would be very
helpful for patients. Not for me.
I think if you, I think it should be offered. Certainly to
say, give people the opportunity, explain to them that
they might not want it straight away, but say, you
know, leave the door open for them and say to them
‘Look, you might not think about it now, you’ve
probably got so many other things on your mind’.
That’s not me. That is not me. Sometimes group
meetings are not me because I want positivity, I do
not want negativity.





White British 55% [6]
White Other 27% [3]
Asian Indian 9% [1]















Surgery and radiotherapy 17% [2]
Missing data 42% [5]
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Discussion
The current findings combined survey data from
NHS cancer clinics across the UK, HCP interviews
and patient interviews regarding the feasibility of re-
cruitment to a RCT of a psychosocial intervention to
improve QoL of those living beyond cancer. The sur-
vey found that conducting a RCT within the NHS
across the UK may be feasible, with most services
agreeing to be involved, to allow staff training and
the running of an intervention within their service.
The interviews with the HCPs were generally positive,
with all participants welcoming RCTs within clinics. The
results replicated previous findings of the practical bar-
riers to recruitment including workload concerns, time
and under-resourced staff [7]. Similarly, the current find-
ings support previous research demonstrating barriers to
recruitment that involved clinical skills such as difficulty
discussing equipoise and the use of terminology that is
difficult for patients [8]. However, the current findings
advanced previous research by suggesting that HCPs
were often protective of their current service provision
and sometimes saw RCTs as a criticism of their practice.
This is an interesting finding as it suggests that to im-
prove recruitment and clinical arrangements an import-
ant focus is to acknowledge current practice and explain
the purpose of RCTs in providing an evidence base for
current practice in specific clinics to provide a case for
providing equal care across the UK.
A further important finding was that patient bar-
riers included demographic factors, suggesting that fu-
ture RCTs should do more to incorporate those that
are perhaps underrepresented in cancer QoL research,
such as men and those from ethnic minorities. Fur-
thermore, language, educational levels and mental
health concerns may be considered a barrier when
faced with extensive written outcome measures –
which should be addressed in RCT designs to ensure
generalisability of findings. Researchers both within
and outside of the NHS would benefit from keeping
in mind patient barriers when designing their research
to improve generalisability of findings and benefit pa-
tients that are often underrepresented in research and
psychological care.
Participants identified factors that may increase mo-
tivation that are simple and easy to incorporate into
RCT research, such as regular contact and communi-
cation from the research team and throughout the
clinical team, regular feedback on the findings and
success of the trial, and in line with previous research
[7] the importance of the effect of the trial on pa-
tients and the individual benefit for clinicians. This
finding is high in external validity as all RCTs would
benefit from introducing these ideas to increase mo-
tivation and recruitment and retention in trials.
The findings from the patient interviews further
suggest that a RCT would be welcomed, for those
that would benefit – suggesting interventions should
be tailored to a patient’s individual needs. The find-
ings demonstrate that those that cope well already
use coping mechanisms that would be developed
throughout a psychosocial intervention; and those
that do not would benefit from support in these key
areas of work, exercise and acceptance.
Limitations
All HCPs who participated in the interviews were
working within clinics which were aware of the
planned trial and within clinics that provided strong
psychological support following active treatment –
which is not always the case [11]. Therefore, the
current findings based on HCPs already within strong
research trusts may overestimate the positive response
to recruitment of centres throughout the NHS more
generally. Similarly, the patients interviewed were
those that volunteered to take part in research and
reported a positive experience of care, which may
provide a biased sample of patients that perhaps rep-
resent those less likely to struggle post treatment and
those less likely to be recruited.
Future research
The SURECAN team have successfully received NIHR
funding to develop the intervention further and then con-
duct a multicentre RCT of a tailored psychological inter-
vention for people who have undergone successful
treatment for cancer, but who have a low QoL. The current
findings suggested that a RCT was feasible within the NHS
and informed the research team how best to improve re-
cruitment and retention within the trial. The team will use
the findings of the current study in the new research
programme, in particular in acknowledging current prac-
tice, providing training and information to HCPs about the
purpose of the RCT and will be feeding back findings to
the clinical team. The success of these strategies will be re-
vealed in our recruitment rates.
Conclusions
Survey results demonstrated that recruitment to a
RCT of a psychosocial intervention for people living
with and beyond cancer would be feasible within the
NHS if specific barriers are addressed. From a clin-
ician point of view, barriers should be addressed to
improve recruitment, particularly training and educa-
tion of clinicians and clear communication. From a
patient perspective, interventions and RCTs should be
tailored to target those not routinely represented in
RCTs.
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Appendix
Table 3 Initial list of codes and themes from the HCP interviews





Time in clinic concerns
Set up of clinics
Clinics busy
Other trials ongoing
I think one of the things we are facing at the minute are just how busy clinics are and
there’s lots of the new technology coming in like new electronic systems, which
means clinic time is squeezed even more. So what I am certainly finding is I am
spending less time with patients and more time at a computer screen, and I am sure
that would have a knock-on effect potentially with trials.
Radiotherapy is the point which the majority of people end their treatment. Now there are
ones that do not get radiotherapy and come through us so there is no one shoe fits everyone.
So, if we had a properly integrated service, which we hope to provide at the future, but do not
at present it would be more straightforward. But it is not integrated now and because it’s not
integrated we have problems.
At the moment because of the design of our department, the patients are not focused into one single
prostate cancer clinic or kidney cancer clinic, we are trying to get the patients in a focused cancer clinic,
so the scenario where you will have these patients coming one after the other through.
And we have in terms of the trial portfolio there’s several clinical trials ongoing but I do not think any, I
think this would be a very good one to recruit patients into because I do not think there will be any
conflict with any other research projects going on.
A lot of the patients may already be in a clinical trial so are having QoL measures as part of that. So it’s
some of the validated QoL ones that are used, validated for head and neck.
Yes, and that might sound harsh but the fact is that we probably have potentially half a dozen studies to
recruit to and even with the best will in the world and it will not happen with a lot of additional admin
to do.
One of the biggest thing is our clinics are really busy and we are really short on physical space. So, there’s
a temptation people will kind of exhaust things if they think it will delay. But if it’s a matter of asking the
screening and saying they will be contacted later I do not see any reason that we could not get good






Criticism of current service
Remembering
I think the wording would probably need to be changed – I think those words are all very
understandable to us as clinicians and scientists and things involved but if I said to my average
patient, how is your QoL, they would not necessary know what that means so I think there would
need to be some description of what we mean, like are they enjoying their life, are there things they
would like to do that they cannot pursue. So, I think it would have to be broken down, and likewise sort
of physical vs the mental so maybe use worked examples, but yeah I think they’d be three very good
punch points to use. I think more in lay speak because those are terms that roll off our tongue, but if you
actually say it to a patient or carer they will be like ‘What do you mean?’ and the likelihood is there will
be assumptions made and therefore we won’t get the right information
The main barrier was that because we think we have quite a good set up already, one of the
nurses was a bit sort of suspicious of the study that it was here to sort of investigate what we do
or if you see what I mean. But X was quite good in that he was here to help us to give us evidence
based on what we do and that no patient would receive less than the current standard of care. Again, I
think addressing those concerns as most of the work will be done by nursing staff not medical, addressing
those concerns and focusing on those would be the best way, reiterating it is a study to help us, to show
that what we already do in some alloyed fashion is already effective given us an evidence base to show it’s
cost-effective and all those supplementary issues. We are keen to get going and be involved in studies
like this















And a lot of, a sizeable proportion, shall we say 30% come from further afield So they are often an hour
away by public transport.
Patients who, quite a lot of our patients have mental health problems, which might mean they do
not want to engage in this sort of thing.
Myself and X felt that there’s definitely going to be a group of patients that will, for whatever reason, not
want to engage.
The patients themselves, despite you know, you could sell them whatever but they do not want to
participate.
In terms of patients coming forward, I think there are just some patients an intervention is just not their
kind of thing. There are some patients you will find will want to access everything and there are
some patients that will just want to go away and forget it all.
Another thing that sometimes impacts on these things is especially male patients, now I do not want to
be sexist but it’s just how I find it, with head and neck cancer it’s very much still such a male
dominated cancer but often they do not like these sorts of things that touch on the psychological
aspects, because they are a man and they have got to be strong and these sorts of things. So I
think that and that was something I talked to X about that with a lot of these patients that would be
suitable for this, we know they need help but they do not and it’s how we actually bridge that gap and try
and get them into an important study like this and ultimately help them
Yes, rather than just, some of them just immediately shut down. I have sometimes mentioned patients
going to our cancer support centre which is an excellent resource, they offer not only counselling, but
complementary therapies and psychological input but often patients will not even let you explain what it’s
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Table 3 Initial list of codes and themes from the HCP interviews (Continued)
Themes Codes Example quotes
about its all ‘No, no, I do not want any of that’. It is bridging that initial sometimes very negative
impressions of that.
The majority of the patients I see, we can say 80–90%, speak enough English to understand and be
consented for an operation so I do not think language barrier will be a problem. In the few cases where, I
think east European and Middle Eastern, people who are not speaking any English, but they are very few,
and regarding cultural, difficult to say, maybe there are some cultures that would accept a little bit less,
that would be less keen to participate in a trial.
The other thing with barriers for our own group would be language. Non-English-speaking people, we do
think about how we will introduce the study to them. We might have to give leaflets in Bengali, for
instance.
Because it’s extraordinarily cosmopolitan and so people come from many different nationalities. I counted
over the years about 80 separate nationalities I have seen and it’s extraordinary, you know most people 20
but 80, that’s something quite different. Most countries you can think of I have seen people from, not all. I
have not seen anyone from Chad.
It’s not language, it’s culture because people have a lot of people of non-European origin,
non-western European origin, intrinsically they do clinical studies, they enjoy it. So, our recruitment
is always lower than it should be, just because of that cosmopolitan affect.
Head and neck, we have a big Bangladeshi population in London and various other ethnic minority groups
and again it’s really again it’s, from your point of view, if patients were, English wasn’t their first language
would they be excluded or would you have translation facilities?
Patients that do not have English as a first language and require interpreters,
not all but a significant amount of our patients are from a low socially economic background and
do not always have great educational skills. But in an interview, they would be fine but I know
sometimes they struggle with the long questionnaires.
I think it’s the patients themselves, how enthusiastic they are about things, because they are all individual
so it would be how the patient feels about things. But you know anything that will improve patients’ QoL



















And I think an academically driven consultant is a great help, which is the case here.
Feedback from patients about how it helped them fed to the recruiting clinicians so we can see
how it’s being helpful.
Positive feedback from our patients saying it had improved them, obviously that would motivate us.
If we had notices up to remind us.
Also making sure all members of the team, whether it be me, a CNS, a ward nurse or a
radiographer, are saying the same thing. Because it’s almost that attrition and you say it enough
times to a patient and they sort of give in. so I think that’s an important thing to make sure we
are not saying different things and it’s not just one of us continuously saying it but it’s the team
that’s looking after the patients that are saying it.
Ease of recruitment is the biggest motivation, that’s number 1
We have not got time to do additional things in clinic and this is a simple issue, if it would be a very
substantive disincentive if there was a lot of paperwork to do and any paperwork of any sort would be
potentially a problem. Make the process as easy as possible and you’ll recruit more patients.
The key thing is essentially we generally are happy towards any kind of research as long as it’s not
(unheard) making us run around emailing, calling, wait a second wait here, two hours, there will be
someone coming or going through paper work or explaining things. That is not what I can do
that would be possible with more written information, further information and probably short
teaching sessions of what would be expected
around the time it will all kick off. I'd want more information and to be kept up to date and things like that
but yeah no problems with discussing trials with patients
Your name on the paper would be good, would be an incentive.
If you say you are recruiting enough patients to the study, you will be part of any scientific production
coming out of it, it depends.
But obviously that would be an incentive, being acknowledged in the paper is always, generally
speaking, an incentive for the contributors.
For CNSs in our team the advantages of them being seen to participate in recruitment of trials is obviously
a good thing on their CV and it gives them a wider scope for their job as well – all of the advantages that
come with being involved in any kind of research.
Just the fact that trials help in the future, so it’s just the fact that every trial is successful and will
help many more patients in the future.
You know it may well be that by identifying these patients early on they may not need so many
appointments later on because you deal with a lot of the issues and concerns they may present with later.
I think the motivation should be there already, especially within oncologists, I think its interweaved into our
beings that the only way to improve the care of our patients and mark the quality of our care is through
trials, so I think that’s the one thing. I think lots of people can make lots of excuses but ultimately it’s about
quality of care and I think some people may need hand held because it is additional work on an
increasingly busy job but I think, my hope is my colleagues see it as I do, that it is as important as giving
the radiotherapy or delivering the chemotherapy to patients, and there’s no role in oncology if you are not
looking to better things all the time
As long as there’s a clear process for referral and that it’s beneficial for the patients.
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Table 3 Initial list of codes and themes from the HCP interviews (Continued)
Themes Codes Example quotes
Well sometimes I have found is sometimes getting other patients of a similar background and age and
things have a chat with them, but sometimes seeing other patients on the ward in a similar situation.
I guess having someone from the research, your end of things keeping regular contact with us
would help, these things do drift sometimes if we do not get any feedback and regular contact,
that’s always helpful.
So, you need to have a dedicated research resource to allow clinicians to interact.
And when I took over that trial we were in the bottom of recruitment as no one was taking an interest. I
spoke to the CI and now they have got a research nurse that comes to the clinic, sits there. So, I spend
the first 15 min of my clinic sitting with them and identifying patients. And then I sit with the patients and
introduce it to them, which means they are more receptive to the research nurse. Half of the research
nurse job is done. As a consultant, you do have a lot of power, because they trust you more.
It will probably help to have someone with a link to the study in clinics. We certainly know the best
recruiting studies are the ones that have either the research assistant or who ever actually in clinic
reminding clinicians of the study, making sure we are asking the questions and giving the patients
information.
So that is what helps a CNS or a research person around in a surround that is not clinical outpatient basis
so it is like in more informal. Time is the only factor, the only problem.
I think rather clinic in breast, it would be useful to have the research fellow there because they have so
many cases and it is a bit different.
The key point is the MDT and the MDT coordinator, and managing the MDT, so maybe we have quite a
lot for research with, for example, UCH on cancer study in preop patients and what they were doing.
There was a research fellow at every MDT that was sitting there, coming with us and listening to all the
cases, and then he says particularly when the stuff at the end or during the consultation, ‘Well, if you are
happy I will do the CAT study for this patient’. We say ‘OK, fine’ and essentially they were arranging
something straight away – the patient had the CAT scan within the research at UCH. But obviously they
were present constantly and we never object, we never say ‘No, I do not want my patient to go through’,
but there was always someone that was there if they were saying to us can you identify every single
patient, yeah I am sure that if you occasionally we would not identify the patient as maybe we forget
about the study with so many studies going simultaneously we do not think who has all the characteristics
to be involved within the study.
With my experience, with previous studies, with a research nurse everything goes well and then we do the
follow-up 12 months or 24 months later, when we do not have a questionnaire then it all becomes a
nightmare. So, I think the most important barrier is to have someone delegated to do all that study, a
centralised research person doing all that, then obviously would be easier.
So, if I understand you correctly, we would be required to fill out a questionnaire – because what would
be ideal is if you had a member of staff present within our clinics. Is that possible?
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